{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:58Z","timestamp":1786119718712,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"DOI":"10.1097\/qai.0b013e318218a713","type":"journal-article","created":{"date-parts":[[2011,3,19]],"date-time":"2011-03-19T02:45:34Z","timestamp":1300502734000},"page":"311-318","source":"Crossref","is-referenced-by-count":33,"title":["Incidence of Tuberculosis in HIV-Infected Patients Before and After Starting Combined Antiretroviral Therapy in 8 Sub-Saharan African HIV Programs"],"prefix":"10.1097","volume":"57","author":[{"given":"Sarala","family":"Nicholas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Sabapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Ferreyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Varaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Pujades-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(06)68383-9","article-title":"Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.","volume":"367","author":"Corbett","year":"2006","journal-title":"Lancet"},{"key":"R5-11-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0962-8479(93)90010-U","article-title":"Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia.","volume":"74","author":"Elliott","year":"1993","journal-title":"Tuberc Lung Dis"},{"key":"R6-11-20210131","first-page":"64","article-title":"HIV-related tuberculosis in South Africaclinical features and outcome.","volume":"86","author":"Wilkinson","year":"1996","journal-title":"S Afr Med J"},{"key":"R7-11-20210131","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R8-11-20210131","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/01.aids.0000232235.26630.ee","article-title":"Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.","volume":"20","author":"Bonnet","year":"2006","journal-title":"AIDS"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1086\/522986","article-title":"Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.","volume":"45","author":"Brinkhof","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R10-11-20210131","first-page":"318","article-title":"Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.","volume":"14","author":"Dembele","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R13-11-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"},{"key":"R14-11-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.","volume":"172","author":"Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2334-9-46","article-title":"Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database.","volume":"9","author":"Zhou","year":"2009","journal-title":"BMC Infect Dis"},{"key":"R18-11-20210131","first-page":"741","article-title":"Extra-pulmonary and smear-negative forms of tuberculosis are associated with treatment delay and hospitalisation.","volume":"14","author":"Whitehorn","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R21-11-20210131","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.aids.0000176221.33237.67","article-title":"Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?","volume":"19","author":"Breen","year":"2005","journal-title":"AIDS"},{"key":"R22-11-20210131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/sti.79.4.337","article-title":"Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy.","volume":"79","author":"Goldsack","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R23-11-20210131","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/01.aids.0000191922.08938.12","article-title":"Response to Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS, 22 July 2005.","volume":"19","author":"John","year":"2005","journal-title":"AIDS"},{"key":"R24-11-20210131","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","article-title":"Immune reconstitution and unmasking of tuberculosis during antiretroviral therapy.","volume":"177","author":"Lawn","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-11-20210131","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/QAD.0b013e3280f7751f","article-title":"Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART.","volume":"21","author":"Park","year":"2007","journal-title":"AIDS"},{"key":"R26-11-20210131","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.293.22.2719","article-title":"Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.","volume":"293","author":"Grant","year":"2005","journal-title":"JAMA"},{"key":"R27-11-20210131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jwh.2007.0353","article-title":"Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.","volume":"17","author":"Braitstein","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"R28-11-20210131","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(09)61348-9","article-title":"Expanding HIV care in Africa: making men matter.","volume":"374","author":"Mills","year":"2009","journal-title":"Lancet"},{"key":"R29-11-20210131","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.socscimed.2009.03.041","article-title":"Drivers of tuberculosis epidemics: the role of risk factors and social determinants.","volume":"68","author":"Lonnroth","year":"2009","journal-title":"Soc Sci Med"},{"key":"R30-11-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ije\/dyp308","article-title":"A consistent log-linear relationship between tuberculosis incidence and body mass index.","volume":"39","author":"Lonnroth","year":"2010","journal-title":"Int J Epidemiol"},{"key":"R31-11-20210131","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/QAD.0b013e3282f09876","article-title":"Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.","volume":"21","author":"Moh","year":"2007","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201108010-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:01:10Z","timestamp":1786042870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201108010-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318218a713","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,1]]}}}